Fewer tears for SCUBA than Muraine in DMEK graft prep

Article

The submerged cornea using backgrounds away (SCUBA) peeling technique may be more effective than the newer Muraine technique for preparing endothelial donor grafts for Descemet membrane endothelial keratoplasty (DMEK).

The submerged cornea using backgrounds away (SCUBA) peeling technique may be more effective than the newer Muraine technique for preparing endothelial donor grafts for Descemet membrane endothelial keratoplasty (DMEK), according to a study published in Cornea.

Researchers from the Department of Ophthalmology, Queen's University, Kingston, ON, Canada, and the University of Ottawa Eye Institute, Ottawa, ON, Canada conducted a prospective ex vivo investigation in a wet-lab setting. The Muraine technique was used to prepare 20 donor corneas for DMEK - 10 of the donor grafts were prepared by a corneal fellow and 10 were prepared by a corneal surgeon. Likewise, 20 donor corneas were prepared for DMEK using the SCUBA technique; again, 10 were prepared by a corneal fellow and 10 were prepared by a corneal surgeon. As the Muraine technique is newer and therefore likely less familiar to the fellow and surgeon, they both performed 10 “practice” procedures using the Muraine technique before starting the study.

The researchers examined the time needed to prepare endothelial grafts and the number of graft tears.

For both the surgeon (301 ± 85 seconds) and the fellow (523 ± 58 seconds), the SCUBA technique had a shorter median time to prepare the grafts than the Muraine technique (359 ± 83 seconds for the surgeon; 543 ± 44 seconds for the fellow). The findings, however, were not statistically significant. 

There was a statistically significant difference in the number of graft tears. There were 5 graft tears (2 by the surgeon, 3 by the fellow), when using the Muraine technique, compared to 0 graft tears when using the SCUBA technique.

“Given the incidence of graft tears in the Muraine group and the need for specialized equipment (the Muraine punch), we conclude that the SCUBA technique may be superior for the preparation of endothelial donor grafts for DMEK,” the researchers wrote. “However, with further refinement, this new technique has the potential to be a reliable alternative method.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.